相关实验视频

Updated: Jul 15, 2026

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

14.3K

对骨和软组织肉瘤的新型全身疗法的益处评估:一个横截面研究

Qiang He1,2, Zhen Wang3, Jie Mei1

  • 1Department of Orthopedics, Nanjing University of Chinese Medicine Affiliated Nanjing Hospital of Traditional Chinese Medicine, Nanjing, China.

Japanese journal of clinical oncology
|July 30, 2024
PubMed
概括

对骨和软组织肉瘤的新型药物疗法显示出有限的临床益处. 十年的研究表明,很少有治疗方法能为患者带来实质性的优势,这凸显了在瘤药物开发方面面临的挑战.

关键词:
临床益处 临床益处 临床益处随机对照试验是随机对照试验.肉瘤 肉瘤是一种肉瘤.系统性治疗是一种全身疗法.

更多相关视频

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.2K
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

9.6K

相关概念视频

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...